Authors: Castilleja, A Ward, NE O'Brian, CA Swearingen, B Swan, E Gillogly, MA Murray, JL Kudelka, AP Gershenson, DM Ioannides, CG

Citation: A. Castilleja et al., Accelerated HER-2 degradation enhanced ovarian tumor recognition by CTL. Implications for tumor immunogenicity, MOL C BIOCH, 217(1-2), 2001, pp. 21-33

Authors: Anderson, BW Peoples, GE Murray, JL Gillogly, MA Gershenson, DM Ioannides, CG

Citation: Bw. Anderson et al., Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals, CLIN CANC R, 6(11), 2000, pp. 4192-4200

Authors: Anderson, RW Kudelka, AP Honda, T Pollack, MS Gershenson, DM Gillogly, MA Murray, JL Ioannides, CG

Citation: Rw. Anderson et al., Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides, CANCER IMMU, 49(9), 2000, pp. 459-468